These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35505430)

  • 1. Current clinical practice for thromboprophylaxis management in patients with Cushing's syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN).
    van Haalen FM; Kaya M; Pelsma ICM; Dekkers OM; Biermasz NR; Cannegieter SC; Huisman MV; van Vlijmen BJM; Feelders RA; Klok FA; Pereira AM;
    Orphanet J Rare Dis; 2022 May; 17(1):178. PubMed ID: 35505430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey.
    Cherenko M; Appelman-Dijkstra NM; Priego Zurita AL; Biermasz NR; Dekkers OM; Klok FA; Reisch N; Aulinas A; Biagetti B; Cannavo S; Canu L; Detomas M; Devuyst F; Falhammar H; Feelders RA; Ferrau F; Gatto F; Grasselli C; van Houten P; Hoybye C; Isidori AM; Kyrilli A; Loli P; Maiter D; Nowak E; Pivonello R; Ragnarsson O; Steenaard RV; Unger N; van de Ven A; Webb SM; Yeste D; Ahmed SF; Pereira AM
    Endocr Connect; 2024 Jun; 13(6):. PubMed ID: 38614126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The thrombotic risk in Cushing's syndrome-questions, answers, and the algorithm to consider in its assessment: part I-thrombotic risk not related to surgery.
    Bryk-Wiązania AH; Minasyan M; Świątkowska-Stodulska R; Undas A; Hubalewska-Dydejczyk A; Webb SM; Valassi E; Gilis-Januszewska A
    Front Endocrinol (Lausanne); 2024; 15():1350010. PubMed ID: 38529392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercoagulability in Cushing's syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols.
    Feelders RA; Nieman LK
    Pituitary; 2022 Oct; 25(5):746-749. PubMed ID: 35881275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A venous thromboembolism risk assessment model for patients with Cushing's syndrome.
    Zilio M; Mazzai L; Sartori MT; Barbot M; Ceccato F; Daidone V; Casonato A; Saggiorato G; Noventa F; Trementino L; Prandoni P; Boscaro M; Arnaldi G; Scaroni C
    Endocrine; 2016 May; 52(2):322-32. PubMed ID: 26113424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgery.
    Isand K; Feelders R; Brue T; Toth M; Deutschbein T; Reincke M; Kršek M; Santos A; Demtröder F; Chabre O; Strasburger CJ; Aulinas Maso A; Volke V; Pereira AM; Lohmann R; Gich Saladich I; ; Webb SM; Wass J; Valassi E
    Eur J Endocrinol; 2024 Jan; 190(1):75-85. PubMed ID: 38146835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with Cushing's syndrome suffer from provoked venous thromboembolism and are anticoagulated in various patterns.
    Bryk-Wiązania AH; Minasyan M; Hubalewska-Dydejczyk A; Gilis-Januszewska A
    Endocr Connect; 2024 Sep; 13(9):. PubMed ID: 39032510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboprophylaxis following cesarean section - a nation-wide survey from Germany.
    Goecke T; Voigt F; Rath W
    J Matern Fetal Neonatal Med; 2020 Jul; 33(14):2359-2365. PubMed ID: 30606064
    [No Abstract]   [Full Text] [Related]  

  • 9. Preventive strategies for hypercoagulation in Cushing's syndrome: when and how.
    Lopes V; Marques O; De Sousa Lages A
    Thromb J; 2023 Jul; 21(1):72. PubMed ID: 37400845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of the current transition of care practice for patients with pituitary disease at Endo-ERN reference centers.
    Shishkov SR; Tuccillo L; Iotova VM; Pivonello R; Pelsma IC; Pereira AM; Biermasz NR
    Endocr Connect; 2023 Feb; 12(2):. PubMed ID: 36524809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous Thromboembolism Prophylaxis: A Narrative Review With a Focus on the High-Risk Critically Ill Patient.
    Lewis TC; Cortes J; Altshuler D; Papadopoulos J
    J Intensive Care Med; 2019; 34(11-12):877-888. PubMed ID: 30165770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment.
    van der Pas R; Leebeek FW; Hofland LJ; de Herder WW; Feelders RA
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):481-8. PubMed ID: 23134530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study.
    Stuijver DJ; van Zaane B; Feelders RA; Debeij J; Cannegieter SC; Hermus AR; van den Berg G; Pereira AM; de Herder WW; Wagenmakers MA; Kerstens MN; Zelissen PM; Fliers E; Schaper N; Drent ML; Dekkers OM; Gerdes VE
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3525-32. PubMed ID: 21880802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboembolic disease in hypercortisolism.
    Capatina C; Fleseriu M
    Curr Opin Endocrinol Diabetes Obes; 2021 Jun; 28(3):330-336. PubMed ID: 33741780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboprophylaxis in adult and paediatric burn patients: A survey of practice in the United Kingdom.
    Vermaak PV; D'Asta F; Provins J; Farr M; Wilson YT
    Burns; 2019 Sep; 45(6):1379-1385. PubMed ID: 31079961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Cohen JM; Emed J; Tagalakis V; Roussin A; Geerts W
    Cochrane Database Syst Rev; 2013 Jul; (7):CD008201. PubMed ID: 23861035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical issues in venous thromboembolism.
    Abad Rico JI; Llau Pitarch JV; Páramo Fernández JA
    Drugs; 2010 Dec; 70 Suppl 2():11-8. PubMed ID: 21162605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery.
    Manetti L; Bogazzi F; Giovannetti C; Raffaelli V; Genovesi M; Pellegrini G; Ruocco L; Iannelli A; Martino E
    Eur J Endocrinol; 2010 Nov; 163(5):783-91. PubMed ID: 20696792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current landscape of European registries for rare endocrine conditions.
    Ali SR; Bryce J; Cools M; Korbonits M; Beun JG; Taruscio D; Danne T; Dattani M; Dekkers OM; Linglart A; Netchine I; Nordenstrom A; Patocs A; Persani L; Reisch N; Smyth A; Sumnik Z; Visser WE; Hiort O; Pereira AM; Ahmed SF
    Eur J Endocrinol; 2019 Jan; 180(1):89-98. PubMed ID: 30407922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enoxaparin administration within 24 hours of caesarean section: a 6-year single-centre experience and patient outcomes.
    Moriuchi K; Chigusa Y; Kondoh E; Murakami R; Ueda Y; Mogami H; Mandai M
    J Obstet Gynaecol; 2019 May; 39(4):451-454. PubMed ID: 30580649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.